RAPAMYCIN EFFECTOR PROTEINS, DNA MOLECULES WHICH ENCODE PROTEINS, ANTI-SENSE DNA MOLECULES WHICH HIBRIDIZE WITH DNA MOLECULES, PROCESSES FOR ISOLATING RAPAMYCIN EFFECTOR PROTEINS, FOR IDENTIFYING IMMUNOMODULATORS, FOR DETECTING RAPAMYCIN ANALOGS AND ...

摘要

This invention comprises novel Rapamycin-FKBP12 binding proteins of mammalian origin for identification, design and synthesis of immunomodulatory, anti-restenosis or anti-tumor agents, as well as fragments of the proteins and the DNA, cDNA, antisense RNA and DNA segments corresponding to the proteins. This invention also comprises methods for isolating the proteins and therapeutic uses related to the proteins.